|
|
||||
![]() |
ImmunoGen, Inc. develops targeted anticancer therapeutics. Our proprietary Targeted Antibody Payload (TAP) technology and strong antibody expertise form the basis for our development of our own products as well as of our partnerships with other companies. |
|||
| built@zoomedia.com | © 2009 ImmunoGen, Inc. | Privacy Policy | Usage Policy Last updated June 23, 2009 | |||